MannKind Launches Educational Website to Raise Awareness of NTM Lung Disease
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., July 31, 2024 (GLOBE NEWSWIRE) — MannKind Corporation (Nasdaq:MNKD), a company focused on the development and commercialization of innovative inhaled therapeutic products and devices for patients with endocrine and orphan lung diseases, announced today the launch of an educational website designed to raise awareness of nontuberculous mycobacterial (NTM) lung disease. LearnAboutNTM.com is launching today in support of World NTM Awareness Day on August 4.